Your browser doesn't support javascript.
loading
Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date.
Lerner, Vladimir; McCaffery, Peter J A; Ritsner, Michael S.
Affiliation
  • Lerner V; Faculty of Health Sciences, Be'er Sheva Mental Health Center, Ben-Gurion University of the Negev, Beersheba, Israel.
  • McCaffery PJ; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK.
  • Ritsner MS; Department of Psychiatry, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. ritsnerm@gmail.com.
CNS Drugs ; 30(4): 269-80, 2016 04.
Article in En | MEDLINE | ID: mdl-26968404
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Receptors, Retinoic Acid Limits: Animals / Humans Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: Israel Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Receptors, Retinoic Acid Limits: Animals / Humans Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: Israel Country of publication: New Zealand